What is an FDA warning letter?

An FDA warning letter is an official notice that the agency believes a company has significantly violated FDA regulations. It identifies the violations, requires prompt correction, and warns that failure to act may lead to enforcement such as seizure, injunction or import refusal.

What is the difference between a Form 483 and a warning letter?

A Form 483 lists inspection observations at the end of an inspection. A warning letter is a later, more serious step issued when the FDA concludes violations are significant and the company's response was inadequate.

Are FDA warning letters public?

Yes. The FDA publishes warning letters in a public database, which is why competitors, suppliers, customers and investors can monitor them.

Regulatory basics

FDA warning letters explained

Updated August 2026 · 6 min read

Direct answer: An FDA warning letter is an official notice that a company has significantly violated FDA rules. It names the violations, demands prompt correction, and signals that enforcement — seizure, injunction, import refusal — may follow. Because these letters are public, they're also a powerful competitive and supplier-risk signal.

What an FDA warning letter actually is

A warning letter is one of the FDA's principal tools for achieving voluntary compliance. It's issued after the agency reviews evidence — often from an inspection, a sample analysis, or a review of promotional materials — and concludes that a violation is significant enough to warrant a formal notice. The letter describes the specific violations, cites the regulations involved, and gives the company a window (typically 15 working days) to respond with corrective actions.

Form 483 vs warning letter

These two are often confused. A Form 483 is issued at the close of an inspection and lists the investigator's observations. It is not a final agency determination. A warning letter comes later, when the FDA reviews the 483, the company's response, and other evidence, and decides the issues are serious and unresolved. In short: a 483 is "here's what we saw"; a warning letter is "this is significant, fix it now."

What happens after a warning letter

The company must respond in writing with a corrective and preventive action (CAPA) plan and timelines. If the FDA is satisfied, it issues a close-out letter. If not, escalation can include product seizure, injunctions, consent decrees, import alerts (for foreign sites), and — for drugs — effects on pending applications. For a public company, a warning letter can move the stock; for a manufacturer, it can jeopardize customer contracts.

Why so many people watch warning letters

Warning letters are public, and that makes them valuable intelligence:

Competitors & CDMOs: a rival manufacturer's warning letter is a signal that its customers may be looking for a more reliable supplier.
Procurement & supplier risk: if one of your suppliers is cited, your own quality and continuity are at risk.
QA & regulatory: patterns in citations and issuing offices reveal what the FDA is focusing on in your product area.
Investors & consultants: enforcement is a leading indicator of operational and financial trouble.

The practical problem: they're hard to track

The FDA posts letters across pages that aren't built for monitoring. If you only care about sterile injectables in the Northeast, or a specific list of suppliers, filtering the raw feed is tedious and easy to miss. That's exactly the gap GMPSignal fills — it watches every new letter, classifies it, and sends you only the ones that match your streams and company watchlist.

Track the letters that matter to you

Set your product areas and supplier watchlist. Get a daily brief. Start free.

Start free →

FAQ

Is an FDA warning letter public? Yes — it's published in the FDA's public database.

How long does a company have to respond? Usually 15 working days.

Does a warning letter mean a product recall? Not necessarily, but it can lead to one if violations affect product safety.